chr7-150947804-GC-G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000238.4(KCNH2):c.2766delG(p.Pro923ArgfsTer51) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000238.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | MANE Select | c.2766delG | p.Pro923ArgfsTer51 | frameshift | Exon 12 of 15 | NP_000229.1 | ||
| KCNH2 | NM_001406753.1 | c.2478delG | p.Pro827ArgfsTer51 | frameshift | Exon 10 of 13 | NP_001393682.1 | |||
| KCNH2 | NM_172057.3 | c.1746delG | p.Pro583ArgfsTer51 | frameshift | Exon 8 of 11 | NP_742054.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | TSL:1 MANE Select | c.2766delG | p.Pro923ArgfsTer51 | frameshift | Exon 12 of 15 | ENSP00000262186.5 | ||
| KCNH2 | ENST00000330883.9 | TSL:1 | c.1746delG | p.Pro583ArgfsTer51 | frameshift | Exon 8 of 11 | ENSP00000328531.4 | ||
| KCNH2 | ENST00000713710.1 | c.2700delG | p.Pro901ArgfsTer51 | frameshift | Exon 12 of 15 | ENSP00000519013.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:2
The c.2766delG pathogenic mutation, located in coding exon 12 of the KCNH2 gene, results from a deletion of one nucleotide at nucleotide position 2766, causing a translational frameshift with a predicted alternate stop codon (p.P923Rfs*51). This alteration has been reported in one individual from a long QT syndrome testing cohort (Tester DJ et al. Heart Rhythm, 2005 May;2:507-17). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Variant summary: The KCNH2 c.2766delG (p.Pro923Argfs) variant results in a premature termination codon, predicted to cause a truncated or absent KCNH2 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as likely pathogenic/pathogenic by our laboratory (e.g. c.2959_2960delCT (p.Leu987fs) and c.3107dupG (p.Asp1037fs). This variant is absent in 11608 control chromosomes (ExAC and publication controls). A publication, Tester_2005, cites the variant in an affected individual for LQTS. A functional study, Hsueh_2008, indicates the variant to cause reduced current amplitude and faster inactivation. Therefore, taking all available lines of evidence into consideration, the variant of interest has been classified as "Likely Pathogenic."
not provided Pathogenic:1
Reported in a patient referred for LQTS genetic testing; however, additional clinical information was not provided (Tester et al., 2005); Not observed in large population cohorts (Lek et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 18593567, 15840476, 19841300)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at